查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874356

肌鈣蛋白：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Troponin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 109 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球肌鈣蛋白市場預計在 2024 年達到 16.9 億美元，預計到 2031 年將達到 30.6 億美元，2025 年至 2031 年的複合年成長率為 8.7%。

本報告對近期與肌鈣蛋白相關的關稅調整和國際策略反制措施進行了全面評估，包括其對跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響。

肌鈣蛋白，或稱肌鈣蛋白複合物，是由三種調節蛋白（肌鈣蛋白C、肌鈣蛋白I和肌鈣蛋白T）組成的複合物，在骨骼肌和心肌（平滑肌除外）收縮中發揮著至關重要的作用。關於肌鈣蛋白的討論通常圍繞著其功能特性展開，特別是效用效用心肌梗塞和心肌細胞死亡特異性標誌物，或作為多種心臟疾病的診斷標誌物和治療靶點的應用價值。肌鈣蛋白檢測測量血液中肌鈣蛋白T或肌鈣蛋白I的濃度。這些蛋白在心肌損傷期間（例如心肌梗塞）會釋放。本報告綜述了肌鈣蛋白檢測試劑盒。

肌鈣蛋白市場的主要驅動力是全球心血管疾病（CVD）負擔的日益加重，尤其是急性心肌梗塞（AMI，俗稱心臟病發作）。肌鈣蛋白是一種心臟生物標記物，在心肌損傷後釋放到血液中，被認為是診斷AMI的黃金標準。由於人口老化、久坐的生活方式以及糖尿病、肥胖和高血壓等相關危險因子的增加，人們對準確、早期心臟診斷的需求正在迅速成長。醫院和急診室越來越依賴高敏感性肌鈣蛋白檢測（hs-cTn）來快速檢測和評估胸痛患者的風險。此外，就地檢驗（POC​​T）技術的進步使得在中心檢查室之外，例如在救護車、診所和農村地區，肌鈣蛋白檢測變得更加快速方便。政府為降低心臟相關死亡率所採取的措施以及人們對早期診斷重要性的日益重視，都在持續推動肌鈣蛋白檢測市場的擴張。

儘管市場需求強勁，肌鈣蛋白市場仍面臨許多挑戰，這些挑戰可能會影響其成長軌跡。其中一個關鍵問題是檢測方法的標準化。由於檢測靈敏度、校準和參考範圍的差異，不同的診斷平台可能會產生不同的肌鈣蛋白值。這種不一致性會導致診斷和臨床決策的不一致。在中低收入國家，由於缺乏靈敏的檢測設備、熟練的醫護人員和可靠的醫療基礎設施，肌鈣蛋白檢測的普及受到阻礙。此外，雖然高靈敏度肌鈣蛋白檢測能夠提高早期檢出率，但也可能檢測到臨床意義不大的升高值，導致過度診斷和假陽性。這可能導致不必要的干涉措施和醫療成本的增加。報銷和監管方面的障礙，特別是針對新型就地檢驗解決方案的障礙，進一步限制了某些地區的市場滲透率。最後，診斷設備製造商之間的競爭以及來自醫療系統和採購機構的價格壓力，都可能威脅到肌鈣蛋白檢測製造商的盈利。

本報告旨在對肌鈣蛋白市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用進行分析。

肌鈣蛋白市場規模、估計和預測以銷售（千）和收入（百萬美元）為單位呈現，基準年為2024年，並包含2020年至2031年的歷史數據和預測數據。我們運用定量和定性分析，幫助讀者制定肌鈣蛋白業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Abbott
  • Roche
  • Siemens Healthcare
  • Beckman Coulter
  • Biomerieux
  • Mitsubishi
  • Quidel
  • Getein Biotech
  • Improve Medical
  • Response Biomedical

按類型分類的細分市場

  • 肌鈣蛋白 I (TnI)
  • 肌鈣蛋白T（TnT）

應用領域

  • 心肌梗塞
  • 急性冠狀動脈症候群
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Troponin was estimated to be worth US$ 1690 million in 2024 and is forecast to a readjusted size of US$ 3006 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Troponin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle. Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death. A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.In this report, we study the troponin assay kit.

The troponin market is primarily driven by the growing global burden of cardiovascular diseases (CVDs), especially acute myocardial infarction (AMI), commonly known as heart attacks. Troponin, a cardiac biomarker released into the bloodstream during heart muscle injury, is considered the gold standard for diagnosing AMI. With the rise in aging populations, sedentary lifestyles, and associated risk factors such as diabetes, obesity, and hypertension, the demand for accurate and early cardiac diagnostics has surged. Hospitals and emergency care centers increasingly rely on high-sensitivity troponin assays (hs-cTn) for rapid detection and risk stratification of patients presenting with chest pain. Moreover, advancements in point-of-care testing (POCT) technologies have enabled faster turnaround times and easier troponin testing outside centralized labs, such as in ambulances, clinics, or rural settings. Government efforts to reduce cardiac-related mortality, as well as growing awareness about the importance of early diagnosis, continue to support the expansion of the troponin testing market.

Despite strong demand, the troponin market faces several challenges that can impact its growth trajectory. One major issue is assay standardization-different diagnostic platforms may yield varying troponin levels due to differences in assay sensitivity, calibration, and reference ranges. This lack of uniformity can lead to inconsistencies in diagnosis and clinical decision-making. In low- and middle-income countries, limited access to high-sensitivity testing equipment, skilled personnel, and reliable healthcare infrastructure hinders widespread adoption. Additionally, while high-sensitivity troponin tests improve early detection, they may also detect clinically insignificant elevations, leading to overdiagnosis or false positives, which can result in unnecessary interventions and increased healthcare costs. Reimbursement and regulatory hurdles, particularly for newer POCT solutions, further constrain market penetration in certain regions. Lastly, competition among diagnostic companies and pricing pressure from healthcare systems and procurement agencies can challenge the profitability of troponin test manufacturers.

This report aims to provide a comprehensive presentation of the global market for Troponin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Troponin by region & country, by Type, and by Application.

The Troponin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Troponin.

Market Segmentation

By Company

  • Abbott
  • Roche
  • Siemens Healthcare
  • Beckman Coulter
  • Biomerieux
  • Mitsubishi
  • Quidel
  • Getein Biotech
  • Improve Medical
  • Response Biomedical

Segment by Type

  • Troponin I (TnI)
  • Troponin T (TnT)

Segment by Application

  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Troponin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Troponin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Troponin Product Introduction
  • 1.2 Global Troponin Market Size Forecast
    • 1.2.1 Global Troponin Sales Value (2020-2031)
    • 1.2.2 Global Troponin Sales Volume (2020-2031)
    • 1.2.3 Global Troponin Sales Price (2020-2031)
  • 1.3 Troponin Market Trends & Drivers
    • 1.3.1 Troponin Industry Trends
    • 1.3.2 Troponin Market Drivers & Opportunity
    • 1.3.3 Troponin Market Challenges
    • 1.3.4 Troponin Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Troponin Players Revenue Ranking (2024)
  • 2.2 Global Troponin Revenue by Company (2020-2025)
  • 2.3 Global Troponin Players Sales Volume Ranking (2024)
  • 2.4 Global Troponin Sales Volume by Company Players (2020-2025)
  • 2.5 Global Troponin Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Troponin Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Troponin Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Troponin
  • 2.9 Troponin Market Competitive Analysis
    • 2.9.1 Troponin Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Troponin Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Troponin as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Troponin I (TnI)
    • 3.1.2 Troponin T (TnT)
  • 3.2 Global Troponin Sales Value by Type
    • 3.2.1 Global Troponin Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Troponin Sales Value, by Type (2020-2031)
    • 3.2.3 Global Troponin Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Troponin Sales Volume by Type
    • 3.3.1 Global Troponin Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Troponin Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Troponin Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Troponin Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Myocardial Infarction
    • 4.1.2 Acute Coronary Syndrome
    • 4.1.3 Others
  • 4.2 Global Troponin Sales Value by Application
    • 4.2.1 Global Troponin Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Troponin Sales Value, by Application (2020-2031)
    • 4.2.3 Global Troponin Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Troponin Sales Volume by Application
    • 4.3.1 Global Troponin Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Troponin Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Troponin Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Troponin Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Troponin Sales Value by Region
    • 5.1.1 Global Troponin Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Troponin Sales Value by Region (2020-2025)
    • 5.1.3 Global Troponin Sales Value by Region (2026-2031)
    • 5.1.4 Global Troponin Sales Value by Region (%), (2020-2031)
  • 5.2 Global Troponin Sales Volume by Region
    • 5.2.1 Global Troponin Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Troponin Sales Volume by Region (2020-2025)
    • 5.2.3 Global Troponin Sales Volume by Region (2026-2031)
    • 5.2.4 Global Troponin Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Troponin Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Troponin Sales Value, 2020-2031
    • 5.4.2 North America Troponin Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Troponin Sales Value, 2020-2031
    • 5.5.2 Europe Troponin Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Troponin Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Troponin Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Troponin Sales Value, 2020-2031
    • 5.7.2 South America Troponin Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Troponin Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Troponin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Troponin Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Troponin Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Troponin Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Troponin Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Troponin Sales Value, 2020-2031
    • 6.3.2 United States Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Troponin Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Troponin Sales Value, 2020-2031
    • 6.4.2 Europe Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Troponin Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Troponin Sales Value, 2020-2031
    • 6.5.2 China Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Troponin Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Troponin Sales Value, 2020-2031
    • 6.6.2 Japan Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Troponin Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Troponin Sales Value, 2020-2031
    • 6.7.2 South Korea Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Troponin Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Troponin Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Troponin Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Troponin Sales Value, 2020-2031
    • 6.9.2 India Troponin Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Troponin Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Troponin Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 Roche
    • 7.2.1 Roche Company Information
    • 7.2.2 Roche Introduction and Business Overview
    • 7.2.3 Roche Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Roche Troponin Product Offerings
    • 7.2.5 Roche Recent Development
  • 7.3 Siemens Healthcare
    • 7.3.1 Siemens Healthcare Company Information
    • 7.3.2 Siemens Healthcare Introduction and Business Overview
    • 7.3.3 Siemens Healthcare Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Siemens Healthcare Troponin Product Offerings
    • 7.3.5 Siemens Healthcare Recent Development
  • 7.4 Beckman Coulter
    • 7.4.1 Beckman Coulter Company Information
    • 7.4.2 Beckman Coulter Introduction and Business Overview
    • 7.4.3 Beckman Coulter Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Beckman Coulter Troponin Product Offerings
    • 7.4.5 Beckman Coulter Recent Development
  • 7.5 Biomerieux
    • 7.5.1 Biomerieux Company Information
    • 7.5.2 Biomerieux Introduction and Business Overview
    • 7.5.3 Biomerieux Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Biomerieux Troponin Product Offerings
    • 7.5.5 Biomerieux Recent Development
  • 7.6 Mitsubishi
    • 7.6.1 Mitsubishi Company Information
    • 7.6.2 Mitsubishi Introduction and Business Overview
    • 7.6.3 Mitsubishi Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Mitsubishi Troponin Product Offerings
    • 7.6.5 Mitsubishi Recent Development
  • 7.7 Quidel
    • 7.7.1 Quidel Company Information
    • 7.7.2 Quidel Introduction and Business Overview
    • 7.7.3 Quidel Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Quidel Troponin Product Offerings
    • 7.7.5 Quidel Recent Development
  • 7.8 Getein Biotech
    • 7.8.1 Getein Biotech Company Information
    • 7.8.2 Getein Biotech Introduction and Business Overview
    • 7.8.3 Getein Biotech Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Getein Biotech Troponin Product Offerings
    • 7.8.5 Getein Biotech Recent Development
  • 7.9 Improve Medical
    • 7.9.1 Improve Medical Company Information
    • 7.9.2 Improve Medical Introduction and Business Overview
    • 7.9.3 Improve Medical Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Improve Medical Troponin Product Offerings
    • 7.9.5 Improve Medical Recent Development
  • 7.10 Response Biomedical
    • 7.10.1 Response Biomedical Company Information
    • 7.10.2 Response Biomedical Introduction and Business Overview
    • 7.10.3 Response Biomedical Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Response Biomedical Troponin Product Offerings
    • 7.10.5 Response Biomedical Recent Development

8 Industry Chain Analysis

  • 8.1 Troponin Industrial Chain
  • 8.2 Troponin Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Troponin Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Troponin Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Troponin Market Trends
  • Table 2. Troponin Market Drivers & Opportunity
  • Table 3. Troponin Market Challenges
  • Table 4. Troponin Market Restraints
  • Table 5. Global Troponin Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Troponin Revenue Market Share by Company (2020-2025)
  • Table 7. Global Troponin Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Troponin Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Troponin Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Troponin Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Troponin Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Troponin
  • Table 13. Global Troponin Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Troponin as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Troponin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Troponin Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Troponin Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Troponin Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Troponin Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Troponin Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Troponin Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Troponin Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Troponin Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Troponin Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Troponin Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Troponin Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Troponin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Troponin Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Troponin Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Troponin Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Troponin Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Troponin Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Troponin Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Troponin Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Troponin Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Troponin Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Troponin Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Troponin Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Troponin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Troponin Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Troponin Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Troponin Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Troponin Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Troponin Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Troponin Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Troponin Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Troponin Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Troponin Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Troponin Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Troponin Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Troponin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Troponin Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Troponin Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Troponin Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Troponin Sales Volume, (2026-2031) & (K Units)
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Troponin Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. Roche Company Information
  • Table 63. Roche Introduction and Business Overview
  • Table 64. Roche Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Roche Troponin Product Offerings
  • Table 66. Roche Recent Development
  • Table 67. Siemens Healthcare Company Information
  • Table 68. Siemens Healthcare Introduction and Business Overview
  • Table 69. Siemens Healthcare Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Siemens Healthcare Troponin Product Offerings
  • Table 71. Siemens Healthcare Recent Development
  • Table 72. Beckman Coulter Company Information
  • Table 73. Beckman Coulter Introduction and Business Overview
  • Table 74. Beckman Coulter Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Beckman Coulter Troponin Product Offerings
  • Table 76. Beckman Coulter Recent Development
  • Table 77. Biomerieux Company Information
  • Table 78. Biomerieux Introduction and Business Overview
  • Table 79. Biomerieux Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Biomerieux Troponin Product Offerings
  • Table 81. Biomerieux Recent Development
  • Table 82. Mitsubishi Company Information
  • Table 83. Mitsubishi Introduction and Business Overview
  • Table 84. Mitsubishi Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Mitsubishi Troponin Product Offerings
  • Table 86. Mitsubishi Recent Development
  • Table 87. Quidel Company Information
  • Table 88. Quidel Introduction and Business Overview
  • Table 89. Quidel Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Quidel Troponin Product Offerings
  • Table 91. Quidel Recent Development
  • Table 92. Getein Biotech Company Information
  • Table 93. Getein Biotech Introduction and Business Overview
  • Table 94. Getein Biotech Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Getein Biotech Troponin Product Offerings
  • Table 96. Getein Biotech Recent Development
  • Table 97. Improve Medical Company Information
  • Table 98. Improve Medical Introduction and Business Overview
  • Table 99. Improve Medical Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Improve Medical Troponin Product Offerings
  • Table 101. Improve Medical Recent Development
  • Table 102. Response Biomedical Company Information
  • Table 103. Response Biomedical Introduction and Business Overview
  • Table 104. Response Biomedical Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Response Biomedical Troponin Product Offerings
  • Table 106. Response Biomedical Recent Development
  • Table 107. Key Raw Materials Lists
  • Table 108. Raw Materials Key Suppliers Lists
  • Table 109. Troponin Downstream Customers
  • Table 110. Troponin Distributors List
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Troponin Product Picture
  • Figure 2. Global Troponin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Troponin Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Troponin Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Troponin Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Troponin Report Years Considered
  • Figure 7. Global Troponin Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Troponin Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Troponin Revenue in 2024
  • Figure 10. Troponin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Troponin I (TnI) Picture
  • Figure 12. Troponin T (TnT) Picture
  • Figure 13. Global Troponin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Troponin Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Troponin Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Troponin Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Troponin Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Myocardial Infarction
  • Figure 19. Product Picture of Acute Coronary Syndrome
  • Figure 20. Product Picture of Others
  • Figure 21. Global Troponin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Troponin Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Troponin Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Troponin Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Troponin Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Troponin Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Troponin Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Troponin Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Troponin Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Troponin Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Troponin Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Troponin Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Troponin Sales Volume (%), (2020-2031)
  • Figure 38. United States Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Troponin Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Troponin Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Troponin Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Troponin Industrial Chain
  • Figure 60. Troponin Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed